About US
Contact us
-
Diabetes is Fastest Growing Pharmaceutical MarketThe market for diabetes treatments is the fastest growing in the pharmaceutical sector, and costs related to the prevention and treatment of the disease are expected to grow to $490bn by 2030 accordin2011/8/15
-
Pfizer to Partner UC for Drug Discovery and Development ProgrammePfizer is set to partner with University of California (UC), San Diego Health Sciences via its Centers for Therapeutic Innovation (CTI) network to accelerate and transform drug discovery and developme2011/8/15
-
Herbal remedies fail to provide safety information on labelsBy Dr Ananya Mandal, MD According to a new study many herbal remedies are not free from side effects as commonly believed. Herbal medicines may not contain all the information that consumers need t2011/8/12
-
Merck Subpoenaed over Marketing PracticesUS-headquartered pharmaceutical major Merck has been subpoenaed by the US Department of Justice, owing to a criminal investigation surrounding marketing practices for three prescription medicines.2011/8/12
-
Merck receives Oliver Wight Class A certificationPharmaceutical and chemical giant Merck KGaA has been awarded Class A certification by Oliver Wight after dramatic improvements in service levels and a €15 million reduction in inventory, at its Darms2011/8/12
-
Medications can be harmed by excessive heatWe all know that people and animals can be harmed by excessive heat; so can medications, states Dr. Amy Peak, director of Drug Information Services for Butler University. Already this summer, air t2011/8/11
-
Biogen, Abbott Announce Positive Trial Results for MS DrugGlobal biotechnology company Biogen Idec and Abbott Laboratories have announced positive results from its multiple sclerosis drug daclizumab HYP. Results of the SELECT Phase 2b trial showed that th2011/8/11
-
Measures for Drug GMP Certification issuedIn order to strengthen the management of drug GMP inspection and certification, further standardize GMP inspection and certification, advance the implementation of Good Manufacturing Practice for Phar2011/8/10
-
SFDA issues Interim Requirements for the Appointment and Evaluation of Drug GMP InspectorsIn order to strengthen the management of the appointment and evaluation of drug GMP inspectors, standardize GMP inspection and certification, advance the implementation of Good Manufacturing Practice2011/8/10
-
New preclinical approach can guide more efficient drug development for brain-related conditionsThe development of drugs for brain-related conditions is not an efficient process; only 8% of candidate drugs that enter clinical trials gain FDA approval. A key reason for this low success rate is2011/8/9